Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Work In Process (2022)

Historic Work In Process for Amylyx Pharmaceuticals (AMLX) over the last 1 years, with Q4 2022 value amounting to $1.7 million.

  • Amylyx Pharmaceuticals' Work In Process changed N/A to $1.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2022, which is N/A changed from last year.
  • Amylyx Pharmaceuticals' Work In Process amounted to $1.7 million in Q4 2022.
  • Amylyx Pharmaceuticals' Work In Process' 5-year high stood at $1.7 million during Q4 2022, with a 5-year trough of $45000.0 in Q3 2022.